Medindia

X

The Availability of Generics, the Desire to Minimize the Use of Steroids and Calcineurin Inhibitors and the Entrance of New Products May Be Driving Shifts in the Management of Kidney Transplant Patients

Thursday, August 26, 2010 General News J E 4
Advertisement

BioTrends Research Group, Inc.

Decision Resources, Inc.

Sharon Funk

Christopher Comfort

404-223-2963

781-993-2597

sfunk@bio-trends.com

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
FDA Accepts Sanofi Pasteur's Application to Expand...
S
Sermo Report Indicates that Ticagrelor is Likely t...